Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | MEDI3617 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
MEDI3617 is an human monoclonal antibody that prevents the binding of angiopoietin 2 to the Tie2 receptor in vitro, and inhibits angiogenesis and tumor growth in vivo (PMID: 22327175, PMID: 29559563). |
| DrugClasses | |
| CAS Registry Number | 1415642-51-1 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Bevacizumab + MEDI3617 | Bevacizumab MEDI3617 | 0 | 0 |
| Carboplatin + MEDI3617 + Paclitaxel | Carboplatin MEDI3617 Paclitaxel | 0 | 0 |
| MEDI3617 | MEDI3617 | 0 | 2 |
| MEDI3617 + Paclitaxel | MEDI3617 Paclitaxel | 0 | 0 |